The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care ...
MAD World Summit 2026 has secured official accreditation from The CPD Group, strengthening its position as a must-attend ...
AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...
NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...
Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...
Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...
Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...
Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary and community care organisations with access to Clarios ...
Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer (CCO). Foster will lead Beam’s commercial organisation and strategy as the company advances multiple product candidates across ...
Healthcare has always been complex, but the pace of change feels greater than ever. Innovation is accelerating, AI is transforming how we work and healthcare delivery continues to evolve. In the UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results